Full-Time

Post Doctoral NIH Research Fellow-Junior Research Fellow

Brown University Health

Brown University Health

1-10 employees

Remote behavioral health care platform analytics

Compensation Overview

$48.1k - $79.4k/yr

Providence, RI, USA

In Person

Category
Lab & Research (1)
Required Skills
Data Analysis
Requirements
  • Ph.D. or M.D./Ph.D. in Molecular Biology, Cell Biology, Biomedical Sciences, or related field
  • Minimum of 0-3 years of relevant postdoctoral research experience
  • Proven expertise in cell culture and Molecular & Cellular Biology Techniques
  • Demonstrated proficiency in in vivo models and surgical techniques
  • Publication record in peer-reviewed journals
Responsibilities
  • Perform transfection using chemical, physical, and viral methods.
  • Establish and maintain stable cell lines for mechanistic studies.
  • Culture various mammalian cell lines.
  • Perform cell-based functional assays (e.g., proliferation, invasion, migration).
  • Carry out molecular biology workflows including PCR/qPCR, siRNA knockdown, and electrophoresis.
  • Perform Western blotting and immunofluorescence staining.
  • Conduct imaging using fluorescence microscopy.
  • Prepare samples for histological analysis.
  • Manage breeding colonies of transgenic mice, genotyping, and sample collection.
  • Perform surgical procedures (e.g., ischemia/reperfusion, unilateral ureteral obstruction).
  • Conduct rodent behavioral analyses and participate in veterinary procedures (injections, surgeries).
  • Perform statistical analysis and data visualization.
Brown University Health

Brown University Health

View

Memoir Health provides a behavioral healthcare platform that enables home-based care for behavioral health and substance use issues. It helps health systems remotely manage patients with tools like remote patient monitoring, scheduling, virtual care, and outcomes management, powered by a data analytics engine that highlights cost-saving opportunities and supports automated workflows and one-click referrals. The platform differentiates itself by automating care journeys and delivering integrated, outcomes-focused care within managed care and other healthcare networks, reducing administrative workload for clinicians. Its goal is to make care more proactive, accessible, and coordinated from patients’ homes, improving outcomes while lowering costs, and Memoir Health was later acquired by Lumeo Health in 2020.

Company Size

1-10

Company Stage

Seed

Total Funding

$7.5M

Headquarters

New York City, New York

Founded

2018

Simplify Jobs

Simplify's Take

What believers are saying

  • Multi-million dollar annual investments expand academic-clinical integration.
  • Rhode Island Hospital and Bradley specialize in behavioral health training.
  • Outpatient networks align with home-based behavioral care coordination.

What critics are saying

  • TriZetto cyber incident disrupts Brown University Health billing March 2026.
  • Lyra Health erodes employer behavioral health market share in New England.
  • Medicaid redetermination disenrolls 20-30% behavioral patients ongoing.

What makes Brown University Health unique

  • STAT program offers free certification for entry-level healthcare roles.
  • Exclusive teaching affiliate of Warren Alpert Medical School at Rhode Island Hospital.
  • Community Health Institute delivers Rhode Island-focused proactive care initiatives.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Brown University Health who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

Paid Sick Leave

Productivity Bonus

Stock Options

Company Equity

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Parental Leave

Loan Assistance

Professional Development Budget

Education allowance

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Commuter Benefits

Meal Benefits

Medical Insurance

Life Insurance

Disability Insurance

Company News

PBN
Apr 25th, 2023
Miriam Hospital’s palliative care program is first in R.I. and one of few in U.S.

LIFESPAN CORP. and HopeHealth launched the state’s first palliative care program in the emergency department of The Miriam Hospital.

PBN
Jan 4th, 2023
Markell named New CFO of Lifespan Corp.

PETER K. MARKELL was named Lifespan Corp. ’s new chief financial officer and executive vice president, starting Jan. 30.

PBN
Dec 26th, 2022
Pareek appointed chief of urology for Lifespan hospitals

PROVIDENCE – Lifespan Corp. has appointed Dr. Gyan Pareek as chief of urology in the department of surgery at Lifespan hospitals and president of Brown Urology Inc.

PBN
Dec 15th, 2022
Lifespan Cancer Institute launches career program for young people of color

PROVIDENCE – The Lifespan Cancer Institute is launching a new program to train high school students of color for a career in cancer research and medicine.

Business Wire
Dec 15th, 2022
Trisalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ (Perio™) Clinical Trial Progress And Pre-Clinical Research Developments

DENVER & CHICAGO--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or “MTAC”), today announced that it has expanded the reach of its ongoing Pressure-Enabled Regional Immuno-Oncology™ (“PERIO™-01” and “PERIO™-02”) clinical program.In recent months TriSalus has opened five new PERIO™-01 (NCT04935229) clinical trial sites, at Stanford University Hospitals, University of California Los Angeles, University of Colorado’s Anschutz Medical Campus, University of Washington Medical Center and University of Miami’s Sylvester Comprehensive Cancer Center, in addition to five previously activated sites. The PERIO™-01 trial is studying an investigational drug, SD-101, delivered intravascularly by the TriNav® Infusion System (“TriNav®”) using the company’s proprietary Pressure-Enabled Drug Delivery™ (“PEDD™”) method of administration. The study is evaluating whether this platform approach with SD-101 and PEDD™ can improve the performance of systemic checkpoint inhibitors in treating patients with uveal melanoma with liver metastases. In addition to these U.S. sites, TriSalus anticipates opening future PERIO™-01 clinical trial sites in the United Kingdom, Europe, and Canada.In parallel, TriSalus opened PERIO™-02 (NCT05220722) trial sites at Columbia University and University of Colorado Denver, along with Rhode Island Hospital – which was announced last month as part of an expanded research collaboration with Lifespan Health System